Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
Nearly one quarter (24.3%) of Americans with chronic obstructive pulmonary disease (COPD) are unable to work as a result of disease, according to the 2013 Behavioral Risk Factor Surveillance System ... Read more
Although the United States is generally regarded as the leader in healthcare and clinical advances, cystic fibrosis patients who are publicly insured in America may have worse outcomes than ... Read more
Conducting a clinical trial to investigate treatment of lung diseases such as idiopathic pulmonary fibrosis (IPF) is no small feat. Not only must pharmaceutical and biological companies enroll enough ... Read more
Hospital readmission for patients with bronchiectasis and COPD is a major problem. In fact, one out of every eleven patients with COPD is readmitted to the hospital only 30 days after discharge. A ... Read more
Scientists at University of Colorado School of Medicine at the Anshutz Medical Campus are uncovering the reasons why adolescents with cystic fibrosis tend to develop cirrhosis, also known as ... Read more
Individuals with chronic lung diseases — such as cystic fibrosis, interstitial lung disease, chronic obstructive pulmonary disease (COPD), and chronic bronchitis — are sometimes recommended to start a pulmonary ... Read more